David S. Battleman - Dec 19, 2022 Form 3 Insider Report for LIPELLA PHARMACEUTICALS INC (LIPO)

Role
Director
Signature
/s/ David S. Battleman
Stock symbol
LIPO
Transactions as of
Dec 19, 2022
Transactions value $
$0
Form type
3
Date filed
1/3/2023, 04:04 PM
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIPO Stock Options Dec 19, 2022 Common Stock 40K $1.25 Direct F1
holding LIPO Stock Options Dec 19, 2022 Common Stock 10K $1.25 Direct F2
holding LIPO Stock Options Dec 19, 2022 Common Stock 10K $3.75 Direct F3
holding LIPO Stock Options Dec 19, 2022 Common Stock 10K $5.00 Direct F4
holding LIPO Stock Options Dec 19, 2022 Common Stock 34K $5.00 Direct F5
holding LIPO Stock Options Dec 19, 2022 Common Stock 10K $5.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number of shares of Common Stock beneficially owned consists of 40,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $1.25 per share.
F2 Number of shares of Common Stock beneficially owned consists of 10,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $1.25 per share.
F3 Number of shares of Common Stock beneficially owned consists of 10,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $3.75 per share.
F4 Number of shares of Common Stock beneficially owned consists of 10,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $5.00 per share.
F5 Number of shares of Common Stock beneficially owned consists of 34,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $5.00 per share.
F6 Number of shares of Common Stock beneficially owned consists of 10,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $5.00 per share.